Claritev (NYSE:CTEV) SVP Nutter Carol Buys 875 Shares of Stock

Claritev (NYSE:CTEV) SVP Nutter Carol acquired 875 shares of the firm’s stock in a transaction on Tuesday, June 9th. The stock was bought at an average price of $28.41 per share, for a total transaction of $24,858.75. Following the completion of the acquisition, the senior vice president owned 46,941 shares of the company’s stock, valued at approximately $1,333,593.81. The trade was a 1.90% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website.

Claritev Price Performance

NYSE:CTEV opened at $29.55 on Thursday. Claritev has a one year low of $11.50 and a one year high of $74.07. The firm’s fifty day moving average price is $22.36 and its two-hundred day moving average price is $26.74. The company has a market cap of $503.83 million, a P/E ratio of -1.71 and a beta of 0.77.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on CTEV shares. Piper Sandler set a $61.00 target price on Claritev in a research report on Wednesday, June 3rd. UBS Group restated a “buy” rating on shares of Claritev in a research note on Tuesday, February 24th. Guggenheim restated a “buy” rating on shares of Claritev in a research note on Tuesday, February 24th. Weiss Ratings restated a “sell (d-)” rating on shares of Claritev in a research note on Friday, March 27th. Finally, Wells Fargo & Company decreased their price target on shares of Claritev from $30.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 19th. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Claritev has an average rating of “Moderate Buy” and an average target price of $33.67.

Institutional Investors Weigh In On Claritev

A number of large investors have recently added to or reduced their stakes in the stock. FAS Wealth Partners Inc. grew its position in Claritev by 49.5% during the first quarter. FAS Wealth Partners Inc. now owns 46,477 shares of the company’s stock worth $759,000 after buying an additional 15,380 shares in the last quarter. Bank of America Corp DE grew its position in Claritev by 146.6% during the first quarter. Bank of America Corp DE now owns 97,795 shares of the company’s stock worth $1,598,000 after buying an additional 58,133 shares in the last quarter. RBF Capital LLC grew its stake in Claritev by 0.8% during the first quarter. RBF Capital LLC now owns 135,314 shares of the company’s stock worth $2,211,000 after buying an additional 1,127 shares in the last quarter. Public Employees Retirement System of Ohio acquired a new stake in Claritev during the first quarter worth about $38,000. Finally, State of Wyoming grew its stake in Claritev by 239.2% during the first quarter. State of Wyoming now owns 2,018 shares of the company’s stock worth $33,000 after buying an additional 1,423 shares in the last quarter. Institutional investors and hedge funds own 87.15% of the company’s stock.

About Claritev

Claritev is a healthcare technology, data and insights company focused on improving affordability,  transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.